Suppr超能文献

甲状腺细针穿刺活检:机构经验

Fine-needle aspiration of thyroid: an institutional experience.

作者信息

Baloch Z W, Sack M J, Yu G H, Livolsi V A, Gupta P K

机构信息

Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, USA.

出版信息

Thyroid. 1998 Jul;8(7):565-9. doi: 10.1089/thy.1998.8.565.

Abstract

In this report we describe our institutional experience with fine-needle aspiration (FNA) of the thyroid. Six hundred sixty-two FNAs were performed in 616 patients in a 3 1/2 year period. The cytological diagnoses were categorized as: negative for malignancy, 455 (69%); indeterminate, 30 (4%); neoplasm/malignant, 105 (16%), and nondiagnostic, 72 (11%) including 29 cases from outside institutions. Surgical follow-up was available in 140 (21%) cases, 95 of which had preceding cytological diagnoses of positive or indeterminate for neoplasm/malignancy. For those cases with definite benign or neoplastic/malignant cytodiagnosis, a sensitivity of 92% and specificity of 84% was achieved. The cumulative false-positive and false-negative rates for these categories were 16% and 7.5%, respectively. On comparing discrepant diagnosis between cytological and histological specimens, two major factors were identified as causes for diagnostic misinterpretations: overlapping cytological features among follicular-derived lesions and inadequate/suboptimal specimens. The cytological features of follicular variant of papillary carcinoma were found to overlap those of hyperplastic/adenomatous nodules and follicular neoplasms due to the presence of abundant thin colloid, monolayer sheets of follicular cells and subtle nuclear features of papillary carcinoma. We suggest that awareness of variable cytological features in follicular lesions (especially in follicular variant of papillary carcinoma), following strict criteria of specimen adequacy in thyroid FNA, and clinicopathological correlation can markedly reduce false-negative results.

摘要

在本报告中,我们描述了我们机构在甲状腺细针穿刺抽吸术(FNA)方面的经验。在3年半的时间里,对616例患者进行了662次FNA。细胞诊断分类如下:恶性阴性,455例(69%);不确定,30例(4%);肿瘤/恶性,105例(16%),以及非诊断性,72例(11%),其中包括29例来自外部机构的病例。140例(21%)病例有手术随访结果,其中95例之前的细胞诊断为肿瘤/恶性阳性或不确定。对于那些细胞诊断明确为良性或肿瘤/恶性的病例,敏感性达到92%,特异性达到84%。这些类别的累积假阳性率和假阴性率分别为16%和7.5%。在比较细胞学和组织学标本之间的诊断差异时,确定了两个主要因素作为诊断错误解读的原因:滤泡源性病变之间细胞特征重叠以及标本不足/欠佳。由于存在丰富的稀薄胶质、滤泡细胞单层片以及乳头状癌的细微核特征,发现乳头状癌滤泡变体的细胞特征与增生性/腺瘤性结节和滤泡性肿瘤的细胞特征重叠。我们建议,了解滤泡性病变(尤其是乳头状癌滤泡变体)中多变的细胞特征,遵循甲状腺FNA标本充足的严格标准,以及临床病理相关性,可以显著降低假阴性结果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验